Mice that had been cured from orthotopic TC1 lung cancers by the combination of (R)-crizotinib, CDDP and PD-1 blockade became resistant against s.c. rechallenge with TC1 tumors (Supplementary Fig. 17k–n). The gene discussed is PDCD1; the disease is lung carcinoma.